Objectives: To test the hypotheses that receipt of Medicaid or Medicare (versus private insurance or self-pay) and low socioeconomic status (SES) leads to increased mortality and lower chances of transplantation among heart transplant (HTx) candidates with bridge to transplant left ventricular assist devices (BTT LVADs).
| INTRODUCTION
Heart failure (HF) is a national epidemic, with adults having a one in five chance of developing this disease in their lifetime. 1 Despite optimal therapy, estimates suggest between 7% and 10% of affected patients will progress to advanced stages of HF. 2 For some of these patients, cardiac transplantation can be a life-saving option, with one-year survival rate approaching 90%. 3 The process of donor heart allocation is intended to be equitable, yet there exist differences in survival after heart transplantation (HTx) by race and health insurance status. 4, 5 For example, in nonelderly adults, 10-year post-transplant survival is lowest among Medicaid recipients, followed by those covered by Medicare, and highest among those privately insured. Due to a severe shortage of donor organs, the time on the waitlist may be considerable; consequently, some candidates die while waiting for an organ. The risk of death while on the wait-list has decreased significantly; 6 yet Hispanic HTx candidates, for example, incur a higher risk of wait-list mortality. 7 Thus, while overall wait-list mortality has decreased, disparities among ethnic groups have remained.
The modern era of continuous flow left ventricular assist devices (LVADs) has improved the quality of life and functional capacity of severely ill HF patients on the HTx wait-list 8 and has resulted in 37% of HTx recipients having been supported by a bridge to transplant (BTT)
LVAD. 3 While short-and long-term mortality after LVAD implantation improves overall survival among Medicare beneficiaries, 9 
| MATERIALS AND METHODS

| Data
| RESULTS
There were Compared to privately insured patients, those with Medicaid insurance were distinguished by younger age at listing, a lower likelihood of LVAD support at listing, earlier time to LVAD implantation after listing, lower educational attainment, and lower neighborhood MHI (Table 1) .
Candidates with Medicare insurance were distinguished by lower In multivariable competing-risks models, the hazard of wait-list mortality was found to be greater among patients with Medicaid insurance than patients with private insurance ( Table 3 ). The final model of access to transplantation revealed lower hazard of HTx associated with African American ethnicity and permanent residence in a neighborhood in the second-lowest quintile of MHI. 
| DISCUSSION
| SES disparities in the LVAD population
In the broader population of patients with LVADs, a previous single- 
| SES disparities in the BTT/HTx population
Previous data in the HTx population have demonstrated that longterm mortality was higher in Medicare and Medicaid patients vs patients using private insurance or self-pay. 
| Significance
Our analysis demonstrates a clear association between insurance status at the time of listing for HTx and mortality while on the wait-list.
Previous data demonstrate improved overall survival on the wait-list with an LVAD, but SES factors may lead to worse outcomes in this population, tempering the benefit of LVAD implantation. Indeed, insurance status exerts a pervasive influence on the composition and outcomes of the transplant recipient population, as publicly insured 
| Conclusion
In conclusion, we examined outcomes related to insurance status in a national cohort of HTx candidates, and found that recipients of T A B L E 3 Multivariable competing-risks regression of heart transplantation among nonelderly adult candidates supported by a left ventricular assist device, with wait-list mortality as a competing outcome (N=3353)
Medicaid insurance have an increased risk of pretransplant mortality.
The disparity is not reflective of SES in general and therefore points to other barriers inherent to Medicaid beneficiaries; this observation warrants further investigation.
| Clinical perspectives
Patients who are recipients of Medicaid insurance at the time of listing for heart transplantation have an increased risk of mortality while on the wait-list. Our data suggest these individuals warrant close monitoring and follow-up while waiting for a donor heart.
| Translational outlook
It is imperative for clinicians to identify the factors which may lead to increased mortality for Medicaid recipients while on the wait-list, and to establish causality. Future studies to address these issues should be conducted in a prospective manner. Due to the limitations of singlecenter studies in the transplant population, we propose that multiinstitutional collaborations should be established to address these concerns.
